In vivo toxicity to lymphoid tissue by 2?-Deoxycoformycin
- 1 January 1978
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 1 (1), 49-51
- https://doi.org/10.1007/bf00253146
Abstract
The enzyme adenosine deaminase has an essential role in lymphocyte metabolism. To examine the in vivo effects of inhibition of this enzyme healthy BDF 1 mice were injected intraperitoneally with 2′-deoxycoformycin, a stoichiometric tight-binding inhibitor of adenosine deaminase. Of the treated animals, 20% died of overwhelming infection, and histopathological examination of these, and surviving animals sacrificed 10 days following treatment indicated a selective toxicity to lymphoid cells. No toxicity to tissues other than the lymphoid system was observed, which is consistent with the hypothesis that 2′-deoxycoformycin offers a new and selective approach to the treatment of lymphoid malignancies.Keywords
This publication has 10 references indexed in Scilit:
- Enhancement of the biological activity of cordycepin (3'-deoxyadenosine) by the adenosine deaminase inhibitor 2'-deoxycoformycinBiochemical Pharmacology, 1976
- ROLE OF ADENOSINE-DEAMINASE IN LYMPHOCYTE-PROLIFERATION1976
- ENHANCEMENT OF ANTITUMOR ACTIVITY OF ARABINOFURANOSYLADENINE BY 2'-DEOXYCOFORMYCIN1976
- Adenosine deaminase activity in leukaemiaBritish Journal of Cancer, 1975
- ADENOSINE-DEAMINASE DEFICIENCY AND COMBINED IMMUNODEFICIENCY SYNDROMEThe Lancet, 1972
- ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITYThe Lancet, 1972
- A study of the tissue distribution of adenosine deaminase in six mammal speciesComparative Biochemistry and Physiology, 1965
- ADENOSINE DEAMINASE ACTIVITY IN LYMPHOID CELLS DURING ANTIBODY PRODUCTIONImmunology & Cell Biology, 1963
- Adenosine deaminaseBiochemical Journal, 1942
- The deaminases of adenosine and adenylic acid in blood and tissuesBiochemical Journal, 1939